Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216723
Status:
COMPLETED
Last Update Posted:
2013-10-23
First Post:
2005-09-14
Brief Title:
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
Sponsor:
Organization:
Korea Otsuka Pharmaceutical Co Ltd
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
3000
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Ecologic or Community |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 1349 |
Who Masked List: